Concepedia

Changyou Zhou

CZ

Statistics

Publications

30

Citations

1.5K

H-Index

19

Active since

1986

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

BeiGene (China)

Chengdu Organic Chemicals (China)

Indiana University – Purdue University Indianapolis

University of Indianapolis

Changyou Zhou is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

1986–2024

30

Publications

30

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Yunhang Guo, Ye Liu, Nan Hu et al. · Journal of Medicinal Chemistry · 2019 · 349 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice

Carina P. Tan, Yue Feng, Yun-Ping Zhou et al. · Diabetes · 2008 · 164 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma

Erik Ladomersky, Lijie Zhai, Kristen L. Lauing et al. · Clinical Cancer Research · 2020 · 110 citations · Full text

Medicine, Immunology, Oncology +17

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

Yao Xiong, Yin Guo, Ye Liu et al. · Neoplasia · 2020 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development

Hexiang Wang, Bo Ren, Ye Liu et al. · Journal of Medicinal Chemistry · 2020 · 78 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

1–5 of 30